dextrose

Does dextrose gel prevent treatment failure in infants with neonatal hypoglycemia?

HYPOGLYCEMIA Neonatal hypoglycemia remains a challenging condition requiring admission to the NICU; significant improvements to intravenous dextrose treatment can be made. This randomized controlled trial assessed the efficacy of oral dextrose gel to treat neonatal hypoglycemia, obviating the need for NICU admisson and IV dextrose treatment. The study revealed that among breastfeeding infants at 35-42 weeks’ gestational age, oral dextrose gel safely reduced neonatal hypoglycemia and prevented NICU admissions. Thus, oral dextrose gel represents a potentially useful therapeutic option for neonatal hypoglycemia.